Form 4: ICU Medical Inc. CEO Vivek Jain Reports Stock Transactions

Vivek Jain, Chairman and CEO of ICU Medical Inc., reports the acquisition and disposal of common stock and restricted stock units on March 15, 2025.

Summary

• On March 15, 2025, Vivek Jain, the Chairman and CEO of ICU Medical Inc., reported transactions involving the company's stock.
• Jain acquired 4,872 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.0.
• Simultaneously, Jain disposed of 2,688 shares of common stock at a price of $143.45.
• Following these transactions, Jain directly owns 108,220 shares of common stock and indirectly owns 88,698 shares through a trust.
• Jain also reports ownership of 4,872 derivative securities, specifically restricted stock units, exercisable on March 15, 2026.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, like the CEO, to report transactions in their company's stock. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• The transactions may provide stakeholders with insights into the CEO's perspective on the company's stock value.
• The disposal of shares could be perceived negatively if investors believe the CEO is losing confidence, but it is more likely related to tax obligations from the vesting of RSUs.

Key Dates